Your phone could soon detect Alzheimer's: new app trial launches
NCT ID NCT06489847
First seen May 01, 2026 · Last updated Jun 23, 2026 · Updated 13 times
Summary
Stanford University is developing a mobile app that uses video of a simple physical test (the Short Physical Performance Battery) to assess physical and cognitive function in older adults. The study will collect video data from 30 healthy volunteers to train the app's AI. The goal is to create an accessible, automated tool that could help detect early signs of Alzheimer's disease and related dementias.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Excellence Research Center
Palo Alto, California, 94304, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SPPB++ mobile application (diagnostic test)
What this could lead to
If successful, this app could provide a simple, objective way to detect early signs of cognitive decline and Alzheimer's disease using a smartphone.
What could go wrong
This is a very early, small study (30 healthy adults) focused on app development, not testing a treatment. It may not translate to real-world use or benefit patients directly.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.